Nocutil (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Nocutil, is a vasopressin analog presented as an oral tablet for systemic use. It is employed to treat central diabetes insipidus, reduce nocturnal enuresis in pediatric patients, and to enhance hemostasis in individuals with hemophilia A or von Willebrand disease.

GNH USA supplies Nocutil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring quality‑controlled distribution with robust logistics across regulated markets. Our compliance program aligns with EU GMP standards and supports timely delivery to end‑users.

Desmopressin acetate is used to manage disorders of water balance and to improve hemostasis in bleeding disorders. - Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Hemophilia A: raises plasma factor VIII levels to aid clot formation. - Von Willebrand disease: promotes release of von Willebrand factor to improve platelet adhesion.

Desmopressin acetate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hyponatremia: low blood sodium due to water retention. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Abdominal cramps: discomfort in the stomach area. - Flushing: transient redness of the skin. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe hyponatremia with seizures: potentially life‑threatening low sodium levels. - Water intoxication: excessive fluid accumulation causing cerebral edema. - Thromboembolic events: clot formation leading to vascular blockage. - Allergic reactions: rash, itching, or anaphylaxis in susceptible individuals.

When prescribing desmopressin acetate, clinicians should observe several safety considerations. - Assess fluid status: monitor serum sodium and fluid balance before and during therapy. - Avoid excessive water intake: advise patients to limit fluid consumption to prevent hyponatremia. - Review concomitant antidiuretic agents: discontinue or adjust other drugs that increase water retention. - Use caution in renal impairment: adjust dose and monitor renal function closely. - Pregnancy and lactation: evaluate risk–benefit, as safety data are limited. - Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Desmopressin acetate can interact with other medicines, affecting its antidiuretic or hemostatic actions.

Major Interactions (Avoid): - Thiazide diuretics: may potentiate antidiuretic effect and increase hyponatremia risk. - Other vasopressin analogs: additive water retention leading to severe hyponatremia. - Carbamazepine: may reduce desmopressin efficacy.

Moderate Interactions (Monitor Closely): - NSAIDs: can enhance antidiuretic effect and affect renal handling. - Anticoagulants (e.g., factor VIII concentrates): monitor hemostatic response. - Alcohol: may increase risk of hyponatremia. - SSRIs: potential for additive hyponatremia.